-
Nat Commun: Shanghai Jiaotong University publishes Chinese pan-genomic analysis of gastric cancer
Time of Update: 2022-09-30
Then, the individual genome is compared with the pangenome as a reference to identify a new genetic variant of the stomach cancer disease - the presence-absence variations (PAVs) of genes.
-
The number of consumers of betel nut, a first-class carcinogen, has exceeded 100 million, and be wary that these first-level carcinogens are hidden around you
Time of Update: 2022-09-30
Does chewing betel nuts cause oral cancer?
Does chewing betel nuts cause oral cancer?
Does chewing betel nuts cause oral cancer?
Does chewing betel nuts cause oral cancer?
The rigorous answer from doctors is that betel nut is a risk factor for oral cancer.
-
What are the imaging tests for stomach cancer?
Time of Update: 2022-09-30
Barium-barium double angiography is also very popular in China, but because it has not been taken seriously, and is greatly affected by the experience of the operator, its early gastric cancer diagnosis rate is low, and it has gradually been replaced by gastroscopy.
-
CAR-T, CAR-NK combined with mesenchymal stem cells, conquer the new hope of solid tumors
Time of Update: 2022-09-30
A recent review published in the journal Biomedicines[2] details the research progress of chimeric antigen receptor cell therapy (including CAR-T, CAR-NK) in the field of cancer treatment and its application in different tumors; The unique ability of mesenchymal stem cells (MSCs) as tumor treatment vectors and the possibility of enhancing the activity of CAR immune cells.
-
Don't miss the oncology journal Hot Talk Top1! Friendly people, super fast reception, from birth letter to clinical coverage!
Time of Update: 2022-09-30
From Netizen 3(Message time2021-09-22) Oncology journals are hotly talking about Top1, and Frontiers in Oncology is the only one.
Introduction to the journalFRONT ONCOL is one of the medical journals of Frontiers, founded in 2011 and published or managed by Frontiers Media S.
-
Learn this "tumor research" method, and you will be one step closer to the country!
Time of Update: 2022-09-30
The results showed that SASP was significantly enriched in MAK683-treated samples, and genes exhibiting high H3K27me3 and positive H3K4me3 modification characteristics on promoters were clustered in the type 5 genome, and MAK683 treatment enhanced SA-β-gal (aging-related β galactosidase) activity in tumor cells in addition to SASP upregulation 。 The authors demonstrated that the CDKN2A/p16, HLA-B, GATA4, and SASP genes (including BMP6, CCL2, CCL25, and MMP2) were significantly upregulated in multiple cells by quantitative PCR (qPCR).
-
European Radiology: Radiomics, "Escorting" the Prognostic Prediction of Gliomas!
Time of Update: 2022-09-30
RRS classifies patients into high-risk and low-risk groupsThis study shows that when combined with clinicopathological features, including EGFR amplification and TERTp mutation status, radiomics can significantly improve survival prediction in patients with IDHwt LGG.
-
Eur Urol Oncol: Oncology outcome prediction for small kidney tumors
Time of Update: 2022-09-30
Recently, researchers from the United States published an article in Eur Urol, in which researchers tried to improve prognostic models that predict metastasis-free survival after nephrectomy by focusing on the clinicopathological features of SRMs associated with adverse outcomes.
-
This MRI sequence achieves "higher, faster, stronger" evaluation of soft tissue tumors!
Time of Update: 2022-09-30
Recently, a study published in the European Journal of Radiology evaluated the diagnostic performance and value of STT intrinsic and peripheral features by comparing the isotropic voxel size of the 4-fold accelerated 3D T2 CAIPIRINHA SPACE sequence with traditional 2D T2 TSE, providing a feasible solution for obtaining rapid, accurate and clear MR images clinically.
-
Clin Cancer Res: ONCOS-102 plus pinemuzumab for advanced melanoma
Time of Update: 2022-09-30
Antibodies to programmed cell death protein-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen (CTLA-4) improved prognosis in patients with unresectable advanced melanoma, and the median overall survival (mOS) of combination therapy was twice that of monotherapy.
-
"Volume" but other researchers? Learn to analyze the letter + experiment, easily get 10 points journal!
Time of Update: 2022-09-30
With the development of bioinformatics, tumor research is increasingly entering the era of big data, and bioinformatics has become the main method of publishing articles in oncology research, but it i
-
Suspected of infecting Schizophorax due to drinking raw water, the woman lost 20 pounds and removed 27 cm long live worms from her brain
Time of Update: 2022-09-30
Doctors remind: Be sure to develop good living habits, avoid drinking raw water, eating undercooked frog meat, snake meat, etc.
Doctors remind: Be sure to develop good living habits, avoid drinking raw water, eating undercooked frog meat, snake meat, etc.
-
Diagnosis and analysis of headache for half a year, MR cases of typical glioblastoma
Time of Update: 2022-09-30
Primary brain lymphoma: often multiple lesions, mostly located around the ventricles, corpus callosum and basal ganglia, less involved in the cortical medullary junction area or cerebellum, and the lesions are mostly uniform and other signals, DWI is more uniform and high signal, and the enhanced scans are mostly "fist-clenched" or "clumpy"-like strengthening.
-
JAMA: The world's first clinical study of small cell lung cancer immunotherapy on JAMA, the positive results of Henlius H drug combined with chemotherapy for first-line treatment of extensive-range small cell lung cancer were released
Time of Update: 2022-09-30
On September 27, 2022, ASTRUM-005, an international multicenter research led by Professor Cheng Ying of Jilin Provincial Cancer Hospital, was published in the Journal of the American Medical Associati
-
JAMA: Longest OS Results for the Treatment of Extensive Small Cell Lung Cancer by Slulizumab (ASTRUM-005 Study)
Time of Update: 2022-09-30
It is expected to benefit the world and fill the clinical gap Small cell lung cancer accounts for about 15% to 20% of bronchial lung cancer, and is the most aggressive subtype of lung cancer, divided into limited small cell lung cancer (LS-SCLC) and ES-SCLC.
-
Quick check Staging of GASTRIC CANCER CT
Time of Update: 2022-09-30
Spiral CT staging of gastric cancer is the main technology of preoperative staging diagnosis of gastric cancer, and it is of great significance to guide the formulation of gastric cancer treatment pla
-
Quick check Staging of GASTRIC CANCER CT
Time of Update: 2022-09-30
Spiral CT staging of gastric cancer is the main technology of preoperative staging diagnosis of gastric cancer, and it is of great significance to guide the formulation of gastric cancer treatment pla
-
Whether 5α-reductase inhibitors affect prostate cancer mortality
Time of Update: 2022-09-21
In randomized trials, such drugs reduced the risk of low-grade prostate cancer while slightly increasing the risk of high-grade prostate cancer; However, many experts believe that the latter finding stems from detection bias (NEJM JW Gen Med Jan 15 2019 and J Natl Cancer Inst 2018; 110:1208 and 1216）。 In the population-based cohort study in Stockholm, Sweden, researchers analyzed prostate cancer mortality in 350,000 men, and physicians prescribed 5-ARI to 8 percent of them.
-
Chuangsheng Group released the extended cohort safety and efficacy data for the first-line treatment of gastric cancer in the form factor of Osemitamab combined with chemotherapy at the 2022 ESMO Annual Meeting press release
Time of Update: 2022-09-21
● Interim data from the first 15 patients with measurable lesions who received TST001 (osemitamab) in combination with CAPOX as the first-line treatment for advanced or metastatic gastric cancer and gastroesophageal junction cancer showed that according to the RECIST 1.
-
Dan's heart is full of vitality Focus on LBCL China exploration, immune checkpoint inhibitors can be expected in the future
Time of Update: 2022-09-21
Professor Gao Yan of the Center for Cancer Prevention and Control of Sun Yat-sen University shared the research progress of PD-1 monoclonal antibody in DLBCL and the application experience of the center.
